Development of a prognostic model for grading chronic graft-versus-host disease

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Chronic graft-versus-host disease (cGVHD) is a significant complication after allogeneic stem cell transplantation.
• Accurate prognostication is crucial for managing cGVHD and improving patient outcomes.
• Existing grading systems may not fully capture the prognostic variability among patients.

Purpose of the Study:

• To stratify patients with cGVHD into distinct risk groups based on prognostic factors.
• To develop a basis for a new, more refined grading system for cGVHD.
• To identify key variables that predict disease-specific survival (DSS) in cGVHD patients.

Main Methods:

• Retrospective analysis of data from 151 patients diagnosed with cGVHD.
• Inclusion of 23 variables assessed at diagnosis and primary treatment failure (PTF).
• Multivariate analysis to identify significant predictors of DSS, leading to the development of prognostic factor scores (PFS).

Main Results:

• 58% of patients failed primary therapy; nonrelapse mortality was 44% after a median follow-up of 7.8 years.
• Significant predictors for DSS at 10 years post-diagnosis (DSS1) included extensive skin involvement, thrombocytopenia, and progressive-type onset.
• Prognostic factor scores derived from these factors showed distinct survival probabilities at 10 years for DSS1 and 5 years for DSS2 (after PTF).

Conclusions:

• The identified prognostic models, based on factors like extensive skin involvement and thrombocytopenia, can effectively stratify cGVHD patients.
• These models provide a foundation for a new grading system to better predict patient outcomes.
• Improved risk stratification can guide clinical decision-making and personalize treatment strategies for cGVHD.